Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial

Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing the previous revision label. This indicates a software update to the page without altering the study information.
    Difference
    0.0%
    Check dated 2026-07-25T10:42:17.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a minor site update rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-03T22:43:05.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page template. This appears to be a backend maintenance update rather than new visible content.
    Difference
    0.0%
    Check dated 2026-06-27T00:22:11.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    New help and navigation sections were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' label was standardized and the footer revision text updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T16:47:26.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new release of the page. No substantive content changes are indicated by this update.
    Difference
    0.0%
    Check dated 2026-06-05T13:19:30.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    The sponsor on the study record changed from Galapagos NV to Lakefront Biotherapeutics NV, updating the record to reflect the current sponsor responsible for the trial.
    Difference
    0.2%
    Check dated 2026-05-22T10:14:38.000Z thumbnail image

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.